Skip to content

Influence of Endurance Exercise and Histamine Receptors on the Gene Expression in Skeletal Muscle

Influence of Endurance Training and Histamine Receptor Antagonists on the Transcriptome Response in Human Muscle

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05131555
Enrollment
14
Registered
2021-11-23
Start date
2021-08-16
Completion date
2021-12-31
Last updated
2024-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise, Histamine

Brief summary

Blocking histamine H1/H2 receptors blunts chronic endurance training adaptations. The current study addresses a twofold research question: What is the influence of endurance training (1) and histamine H1 and H2 signaling (2) on the gene expression in human skeletal muscle. Results from this study will yield more insights into the molecular mechanisms of adaptations to exercise training.

Interventions

DRUGPlacebo: Placebo + exercise training.

Oral placebo Exercise training: Interval-based cycling exercise

DRUGH1 blockade: H1 receptor antagonist + exercise training

H1 blockade: oral blockade Exercise training: Interval-based cycling exercise

DRUGH2 Blockade: H2 receptor antagonist + exercise training

H2 blockade: oral blockade Exercise training: Interval-based cycling exercise

Sponsors

Research Foundation Flanders
CollaboratorOTHER
University Ghent
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

Randomized double-blinded placebo-controlled cross-over interventional study

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Male and female * 18-45 years * not to medium physically active

Exclusion criteria

* Smoking * Chronic disease * Supplement or medication intake * Seasonal allergies

Design outcomes

Primary

MeasureTime frameDescription
Change in muscle transcriptome (direct response)On each test-day: 0 minutes after the exercise training versus at rest.RNA-sequencing
Change in muscle transcriptome (delayed response)On each test-day: 180 minutes after the exercise training versus at rest.RNA-sequencing
Muscle glycogen depletionOn each test-day: 0 minutes after the exercise training versus at rest.Fluorometric determination of muscle glycogen levels
Muscle glycogen resynthesisOn each test-day: 180 minutes after the exercise training versus at rest.Fluorometric determination of muscle glycogen levels
Plasma volume changeChange from rest to different time-points after exercise (0, 30, 60, 120 and 180 minutes after the exercise training).Plasma volume based on hemoglobin and hematocrit concentration.

Secondary

MeasureTime frameDescription
Heart rate during the exercise trainingContinuously during training on each test-day.Heart rate during the exercise training.
Muscle signaling pathways relevant for glucose metabolism and cardiovascular healthOn each test-day: at rest, 0 minutes and 180 minutes after the exercise training.Phosphorylation status of proteins assessed by Western Blotting
Blood lactateOn each test-day at 10 time-points: at rest, during exercise and 0, 30, 60, 120 and 180 minutes after the exercise training.Capillary lactate concentration.
Blood glucoseOn each test-day at 10 time-points: at rest, during exercise and 0, 30, 60, 120 and 180 minutes after the exercise training.Capillary glucose concentration.
Blood histamineOn each test-day at 6 time-points: at rest and 0, 30, 60, 120 and 180 minutes after the exercise training.histamine concentration in blood samples.
Blood insulinOn each test-day at 6 time-points: at rest and 0, 30, 60, 120 and 180 minutes after the exercise training.insulin concentration in blood samples.

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026